Thioholgamide A, a New Anti-Proliferative Anti-Tumor Agent, Modulates Macrophage Polarization and Metabolism

Natural products represent powerful tools searching for novel anticancer drugs. Thioholgamide A (thioA) is a ribosomally synthesized and post-translationally modified peptide, which has been identified as a product of Streptomyces sp. MUSC 136T. In this study, we provide a comprehensive biological profile of thioA, elucidating its effects on different hallmarks of cancer in tumor cells as well as in macrophages as crucial players of the tumor microenvironment. In 2D and 3D in vitro cell culture models thioA showed potent anti-proliferative activities in cancer cells at nanomolar concentrations. Anti-proliferative actions were confirmed in vivo in zebrafish embryos. Cytotoxicity was only induced at several-fold higher concentrations, as assessed by live-cell microscopy and biochemical analyses. ThioA exhibited a potent modulation of cell metabolism by inhibiting oxidative phosphorylation, as determined in a live-cell metabolic assay platform. The metabolic modulation caused a repolarization of in vitro differentiated and polarized tumor-promoting human monocyte-derived macrophages: ThioA-treated macrophages showed an altered morphology and a modulated expression of genes and surface markers. Taken together, the metabolic regulator thioA revealed low activities in non-tumorigenic cells and an interesting anti-cancer profile by orchestrating different hallmarks of cancer, both in tumor cells as well as in macrophages as part of the tumor microenvironment.

[1]  Y. Rebets,et al.  Engineering of Streptomyces lividans for heterologous expression of secondary metabolite gene clusters , 2020, Microbial Cell Factories.

[2]  Kol Jia Yong,et al.  New High-throughput Screen Identifies Compounds That Reduce Viability Specifically In Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation. , 2019, Gastroenterology.

[3]  F. Sotgia,et al.  Thioalbamide, A Thioamidated Peptide from Amycolatopsis alba, Affects Tumor Growth and Stemness by Inducing Metabolic Dysfunction and Oxidative Stress , 2019, Cells.

[4]  Yufei Wang,et al.  Immune effects of glycolysis or oxidative phosphorylation metabolic pathway in protecting against bacterial infection , 2019, Journal of cellular physiology.

[5]  Wenjun Chang,et al.  Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer , 2019, Front. Immunol..

[6]  W. Willmore,et al.  Protein quantification and visualization via ultraviolet-dependent labeling with 2,2,2-trichloroethanol , 2019, Scientific Reports.

[7]  H. Ikeda,et al.  Mechanism of Action of Prethioviridamide, an Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptide with a Polythioamide Structure. , 2019, ACS chemical biology.

[8]  L. Galluzzi,et al.  Macrophages and Metabolism in the Tumor Microenvironment. , 2019, Cell metabolism.

[9]  J. Fletcher,et al.  Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish , 2019, Cell.

[10]  J. Varner,et al.  Targeting Tumor-Associated Macrophages in Cancer. , 2019, Trends in immunology.

[11]  Shuyi Wang,et al.  Elevated CD163+/CD68+ Ratio at Tumor Invasive Front is Closely Associated with Aggressive Phenotype and Poor Prognosis in Colorectal Cancer , 2019, International journal of biological sciences.

[12]  Brian Ruffell,et al.  Macrophages as regulators of tumour immunity and immunotherapy , 2019, Nature Reviews Immunology.

[13]  A. R. Fernandes,et al.  Targeting Tumor Microenvironment for Cancer Therapy , 2019, International journal of molecular sciences.

[14]  J. Pollard,et al.  Targeting macrophages: therapeutic approaches in cancer , 2018, Nature Reviews Drug Discovery.

[15]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[16]  S. Bruner,et al.  Heterologous Production of Microbial Ribosomally Synthesized and Post-translationally Modified Peptides , 2018, Front. Microbiol..

[17]  Ambrose J. Carr,et al.  Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment , 2018, Cell.

[18]  Geoff S. Higgins,et al.  Oxidative Phosphorylation as an Emerging Target in Cancer Therapy , 2018, Clinical Cancer Research.

[19]  Wei Chen,et al.  The phenotype of peritoneal mouse macrophages depends on the mitochondria and ATP/ADP homeostasis. , 2017, Cellular immunology.

[20]  A. Kriegstein,et al.  Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment , 2017, Genome Biology.

[21]  S. Loesgen,et al.  The natural product mensacarcin induces mitochondrial toxicity and apoptosis in melanoma cells , 2017, The Journal of Biological Chemistry.

[22]  R. Müller,et al.  Thioholgamides: Thioamide-Containing Cytotoxic RiPP Natural Products. , 2017, ACS chemical biology.

[23]  M. Distel,et al.  Quo natas, Danio?—Recent Progress in Modeling Cancer in Zebrafish , 2017, Front. Oncol..

[24]  B. Brüne,et al.  Cancer cell and macrophage cross‐talk in the tumor microenvironment , 2017, Current opinion in pharmacology.

[25]  L. O’Neill,et al.  Macrophage Immunometabolism: Where Are We (Going)? , 2017, Trends in immunology.

[26]  Zhenxin Wang,et al.  The Inflammatory CXC Chemokines, GROαhigh, IP-10low, and MIGlow, in Tumor Microenvironment Can Be Used as New Indicators for Non-small Cell Lung Cancer Progression , 2017, Immunological investigations.

[27]  Matthew G. Vander Heiden,et al.  Understanding the Intersections between Metabolism and Cancer Biology , 2017, Cell.

[28]  Alberto Mantovani,et al.  Tumour-associated macrophages as treatment targets in oncology , 2017, Nature Reviews Clinical Oncology.

[29]  P. Limburg,et al.  High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cells. , 2016, Rheumatology.

[30]  Mila Ljujic,et al.  The integrated stress response , 2016, EMBO reports.

[31]  H. Gabra,et al.  Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer , 2016, Cell Death and Differentiation.

[32]  D. Newman,et al.  Natural Products as Sources of New Drugs from 1981 to 2014. , 2016, Journal of natural products.

[33]  B. Brüne,et al.  Killing Is Not Enough: How Apoptosis Hijacks Tumor-Associated Macrophages to Promote Cancer Progression. , 2016, Advances in experimental medicine and biology.

[34]  A. Branch,et al.  A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene. , 2015, Journal of hepatology.

[35]  Jian Huang,et al.  Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis , 2015, PloS one.

[36]  A. Zumbusch,et al.  Lipid droplets as a novel cargo of tunnelling nanotubes in endothelial cells , 2015, Scientific Reports.

[37]  G. Natoli,et al.  Macrophages and cancer: from mechanisms to therapeutic implications. , 2015, Trends in immunology.

[38]  G. Dellaire,et al.  Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era , 2014, Disease Models & Mechanisms.

[39]  Ajit S. Divakaruni,et al.  Analysis and interpretation of microplate-based oxygen consumption and pH data. , 2014, Methods in enzymology.

[40]  A. Friedl,et al.  Stain-Free technology as a normalization tool in Western blot analysis. , 2013, Analytical biochemistry.

[41]  M. Zucchetti,et al.  Role of macrophage targeting in the antitumor activity of trabectedin. , 2013, Cancer cell.

[42]  C. Ries,et al.  In Vitro Generation of Monocyte-Derived Macrophages under Serum-Free Conditions Improves Their Tumor Promoting Functions , 2012, PloS one.

[43]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[44]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[45]  H. Hammad,et al.  Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis , 2011, Allergy.

[46]  S. Gordon,et al.  Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. , 2010, Blood.

[47]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[48]  M. Pedriali,et al.  Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer , 2007, European Respiratory Journal.

[49]  S. Keam,et al.  Trabectedin , 2012, Drugs.

[50]  M. Daha,et al.  IL-10-producing macrophages preferentially clear early apoptotic cells. , 2006, Blood.

[51]  K. Shin‐ya,et al.  Thioviridamide, a Novel Apoptosis Inducer in Transformed Cells from Streptomyces olivoviridis , 2006, The Journal of Antibiotics.

[52]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[53]  Alan G. Porter,et al.  Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis* , 1998, The Journal of Biological Chemistry.

[54]  M. Westerfield.  The zebrafish book : a guide for the laboratory use of zebrafish (Danio rerio) , 1995 .